Literature DB >> 26857240

Unclassifiable arrhythmic cardiomyopathy associated with Emery-Dreifuss caused by a mutation in FHL1.

I San Román1, M Navarro1, F Martínez2, L Albert1, L Polo3, J Guardiola4, E García-Molina1, C Muñoz-Esparza1, J M López-Ayala1, M Sabater-Molina1,5, J R Gimeno1,5.   

Abstract

Emery-Dreifuss muscular dystrophy (EDMD) is a heterogeneous genetic disorder characterized by peripheral muscular weakness often associated with dilated cardiomyopathy. We characterize clinically a large family with a mutation in FHL1 gene (p.Cys255Ser). Penetrance was 44%, 100% for males and 18% for females. The heart was the main organ involved. Affected adult males had mild hypertrophy, systolic dysfunction and restriction with non-dilated ventricles. Carriers had significant QTc prolongation. The proband presented with resuscitated cardiac arrest. There were two transplants. Pathological study of explanted heart showed fibrofatty replacement and scarring consistent with arrhythmogenic cardiomyopathy and prominent left ventricular trabeculations. Myopathic involvement was evident in all males. Females had no significant neuromuscular disease. Mutations in FHL1 cause unclassifiable cardiomyopathy with coexisting EDMD. Prognosis is poor and systolic impairment and arrhythmias are frequent. Thrombopenia and raised creatine phosphokinase should raise suspicion of an FHL-1 disorder in X-linked cardiomyopathy.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Emery-Dreifuss muscular dystrophy; FHL1; cardiomyopathy; mutation

Mesh:

Substances:

Year:  2016        PMID: 26857240     DOI: 10.1111/cge.12760

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

Review 1.  Four and a half LIM domain protein signaling and cardiomyopathy.

Authors:  Yan Liang; William H Bradford; Jing Zhang; Farah Sheikh
Journal:  Biophys Rev       Date:  2018-06-20

Review 2.  Understanding the molecular basis of cardiomyopathy.

Authors:  Marie-Louise Bang; Julius Bogomolovas; Ju Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-11-19       Impact factor: 5.125

3.  Cardiomyopathy and altered integrin-actin signaling in Fhl1 mutant female mice.

Authors:  Akatsuki Kubota; Martí Juanola-Falgarona; Valentina Emmanuele; Maria Jose Sanchez-Quintero; Shingo Kariya; Fusako Sera; Shunichi Homma; Kurenai Tanji; Catarina M Quinzii; Michio Hirano
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 5.121

4.  A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism.

Authors:  Nir Pillar; Oren Pleniceanu; Mingyan Fang; Limor Ziv; Einat Lahav; Shay Botchan; Le Cheng; Benjamin Dekel; Noam Shomron
Journal:  Hum Genet       Date:  2017-04-25       Impact factor: 4.132

5.  Three novel FHL1 variants cause a mild phenotype of Emery-Dreifuss muscular dystrophy.

Authors:  Josefine D S Borch; Thomas Krag; Sonja D Holm-Yildiz; Hakan Cetin; Tuva A Solheim; Freja Fornander; Volker Straub; Morten Duno; John Vissing
Journal:  Hum Mutat       Date:  2022-07-16       Impact factor: 4.700

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.